• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for deadly

deadly

Bodywork: How the virus spread so far so fast

April 28, 2020

How did COVID-19 spread to every nook and cranny of the globe – and so quickly?

Filed Under: Bodywork, COVID-19 News Tagged With: bodywork, coronavirus, covid-19, covid19, deadly, far, fast, news, newsok, OKC, Oklahoma Medical Research Foundation, OMRF, sick, spread, testing, virus

Oblato acquires all rights to glioblastoma drug from OMRF

October 29, 2018

Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.

Filed Under: News, Technology Ventures News Tagged With: 007, americans, brain, cancer, clinical, deadly, diagnosis, drug, edward kennedy, Gtree, james battiste, john mccain, Manu Nair, mike schuster, model, news, Norman, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Stephenson Cancer Center, technology, testing, therapy, Towner, treatment, trial, tumor, university of oklahoma

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

OMRF researcher tests new approach for treating deadly blood infection

July 18, 2017

Lupu’s findings were published in the Proceedings of the National Academy of Sciences.

Filed Under: News Tagged With: bacteria, biomedical, blood, Coggeshall, complement activation system, condition, damage, deadly, defense, drug, er, failure, Florea, Florea Lupu, hospital, immune system, journal, K., lab, Lupu, NIAID, NIGMS, NIH, OKC, Oklahoma, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, organ, pathogens, pharma, PNAS, ra pharma, research, science, scientist-news, sepsis, therapy

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace